TMCI's Business Model
Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical improvement. The company also provides Lapiplasty Mini-Incision precision system. In addition, it offers products to address ancillary surgical procedures, including akin osteotomies, weil osteotomies, intercuneiform stabilization, lesser tarsometatarsal joint fusions, and autograft bone harvesting, as well as for MTP fusion. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra Beach, Florida.
| Sector & Industry | Healthcare / Medical - Devices |
| Website | https://www.treace.com |
| CEO (Chief Executive Officer) | John T. Treace |
| Number of Employees | |
| IPO date | April 23, 2021 |
TMCI Latest News
|
|
|
|
|
|
|
|
|
|
| Contact | |
|---|---|
| Country | US |
| Address | 203 Fort Wade Road |
| City | Ponte Vedra |
| State | FL |
| Phone | 904 373 5940 |
| Zip Code | 32081 |
| Other Identifiers | |
| CIK | 0001630627 |
| ISIN | US89455T1097 |
| CUSIP | 89455T109 |
| Open | 1.94 |
| Previous Close | 1.9 |
| Volume | 401.4 Thou. |
| Average Volume | 773.2 Thou. |
| Day’s Range | 1.86 – 1.965 |
| 52 Week Range | 1.86-10.3 |
| MA (50) | 2.5202 |
| MA (200) | 5.16348 |
| Market Cap | 118.5 Mil. |
| Shares Out. | 63.72 Mil. |
| Earnings Date | Feb 27, 2026 |
| Beta | |
| Last Dividend | |
| EPS | |
| PE | |
Industry Competitors for TMCI
|
Company
|
PE Ratio | Market Cap |
|---|---|---|
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|